Nurix Therapeutics (NRIX) Non-cash Items (2019 - 2022)

Nurix Therapeutics (NRIX) has 4 years of Non-cash Items data on file, last reported at $3.2 million in Q3 2022.

• Non-cash Items for Q3 2022 came in at $3.2 million, down 94.18% year-over-year; the trailing twelve-month figure through Aug 2022 was $3.2 million (down 94.18% YoY), and the FY2021 annual result was $65.7 million, down 53.49% from the prior year.
• Non-cash Items advanced to $3.2 million in Q3 2022 per NRIX's latest filing, from $2.9 million in the prior quarter.
• Over five years, Non-cash Items peaked at $141.2 million in Q4 2020 and troughed at $762000.0 in Q4 2019.
• A 4-year average of $32.6 million and a median of $3.1 million in 2020 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2020 and 2022: Non-cash Items soared 18436.61% in 2020, then slumped 94.18% in 2022.
• A 4-year view of Non-cash Items shows it stood at $762000.0 in 2019, then soared by 18436.61% to $141.2 million in 2020, then slumped by 53.49% to $65.7 million in 2021, then slumped by 95.14% to $3.2 million in 2022.
• Business Quant data shows NRIX's Non-cash Items at $3.2 million in Q3 2022, $2.9 million in Q2 2022, and $2.8 million in Q1 2022.